rs587783695
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003482.4(KMT2D):c.15061C>T(p.Arg5021*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003482.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Kabuki syndrome 1 Pathogenic:6
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with Kabuki syndrome 1 (MIM#147920). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity (PMID: 21882399). (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been classified as pathogenic or likely pathogenic by multiple clinical laboratories in ClinVar, and has been observed in individuals with Kabuki syndrome in the literature (PMID: 30107592). (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
The heterozygous p.Arg5021Ter variant in KMT2D was identified by our study in one individual with Brown syndrome, developmental delay, sensorineural hearing loss, gastroesophageal reflux, pes planus, and cerebellar malformations and white matter anomalies on brain MRI, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Engle lab (https://kirbyneuro.org/EngleLab/). Trio genome analysis showed this variant to be de novo. We believe this is a possible phenotype expansion for Kabuki syndrome 1. The p.Arg5021Ter variant in KMT2D has been previously reported in 5 unrelated individuals with Kabuki syndrome 1 (PMID: 29304373, PMID: 29283410, PMID: 30107592, PMID: 29536651, PMID: 22126750). The number of reported affected individuals with this variant is greater than expected compared to non-affected individuals with this variant. This variant has also been reported in ClinVar (Variation ID: 158734) and has been interpreted as pathogenic or likely pathogenic by multiple submitters. This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 5021, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the KMT2D gene is an established disease mechanism in Kabuki syndrome 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Kabuki syndrome 1. ACMG/AMP Criteria applied: PVS1, PS2_Supporting, PS4, PM2_Supporting (Richards 2015). -
- -
- -
not provided Pathogenic:3
Identified in multiple individuals with a clinical diagnosis of Kabuki syndrome (Banka et al., 2012; Cocciadiferro et al., 2018); Identified in the mosaic state in an individual with dysmorphic facial features, borderline intellectual disability, and emotional dysregulation (Lepri et al., 2017); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 29283410, 29536651, 30107592, 22126750) -
- -
KMT2D: PVS1, PM2, PS4:Supporting -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at